Beck Greener competitive analysis

Explore patent oppositions filed by Beck Greener against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 9, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Drug Delivery SystemsPEARL THERAPEUTICSAug 28, 2024
Methods Of Treating Ocular ConditionsOYSTER POINT PHARMASep 9, 2021
Nasal Delivery DevicesOPTINOSEAug 18, 2021
Pharmaceutical CompositionMEXICHEM FLUOR DE CVAug 4, 2021
Nasal DeliveryOPTINOSEJun 8, 2021
Method For Measuring Flow Features In An Inhaler, Inhaler And SystemNOVARTISMay 26, 2021
Pharmaceutical CompositionMEXICHEM FLUOR DE CVDec 23, 2020
Formulation Comprising Glycopyrrolate, Method And ApparatusVECTURADec 22, 2020
Dry Powder Formulations Comprising VilanterolARVEN ILAC SANAYI VE TICARETOct 1, 2020
Vilanterol FormulationsARVEN ILAC SANAYI VE TICARETOct 1, 2020

Latest publications and patents of Beck Greener New

Explore the latest publications and patents granted to Beck Greener, showcasing their recent innovations and technological advancements.

Latest PTAB cases involving Beck Greener

Discover the latest PTAB cases involving Beck Greener, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Beck Greener with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 9, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
BECK GREENER12 - - -
ARVEN ILAC SANAYI VE TICARET111 - -
MEXICHEM FLUOR DE CV5518 - -
OPTINOSE - 4 - -